#1 Clinical Trials Search in Europe

Levocetirizine Dihydrochloride

Levocetirizine Dihydrochloride, a medication used to treat various allergic conditions, has been the subject of several clinical trials. These studies aim to evaluate its efficacy and safety in treating conditions such as seasonal and perennial allergic rhinitis, chronic idiopathic urticaria, and allergic cough in children. The trials compare Levocetirizine to other antihistamines and placebos, assessing its performance in reducing allergy symptoms and improving patients’ quality of life.

Table of Contents

What is Levocetirizine Dihydrochloride?

Levocetirizine Dihydrochloride is a medication used to treat various allergic conditions. It belongs to a class of drugs called antihistamines, which help reduce allergy symptoms. Levocetirizine is also known by the brand name Xyzal[1]. This medication is a more refined version of the antihistamine cetirizine, designed to be more effective and potentially cause fewer side effects[6].

Conditions Treated by Levocetirizine

Levocetirizine is used to treat several allergic conditions, including:

  • Seasonal Allergic Rhinitis (SAR): This is also known as hay fever, which occurs during specific seasons when certain pollens are in the air[4].
  • Perennial Allergic Rhinitis (PAR): This is a year-round allergy, often caused by indoor allergens like house dust mites[2].
  • Chronic Idiopathic Urticaria (CIU): This is a condition characterized by recurring hives (itchy, raised welts on the skin) of unknown cause[7].
  • Allergic Cough in Children: Levocetirizine has been studied for treating recurrent cough associated with other allergic symptoms in young children[3].

How Levocetirizine Works

Levocetirizine works by blocking the effects of histamine, a substance your body produces during an allergic reaction. By doing this, it helps reduce symptoms such as sneezing, runny nose, itchy or watery eyes, and itchy skin. The medication typically starts working within one hour of taking it and can provide relief for up to 24 hours[6].

Dosage Forms and Administration

Levocetirizine is available in several forms:

  • Tablets: The most common form is a 5 mg tablet, taken once daily[1].
  • Oral Drops: For young children, a liquid form is available. The dosage is typically 0.125 mg/kg twice daily for children aged 1-2 years[3].

The medication can be taken with or without food. In clinical trials, it was often administered in the evening[2].

Efficacy of Levocetirizine

Several studies have demonstrated the effectiveness of Levocetirizine in treating allergic conditions:

  • For Seasonal Allergic Rhinitis, Levocetirizine has shown significant improvement in reducing symptoms like sneezing, runny nose, and itchy eyes[4].
  • In Perennial Allergic Rhinitis, the medication has been effective in increasing the number of “comfortable days” for patients[2].
  • For Chronic Idiopathic Urticaria, Levocetirizine has demonstrated efficacy in reducing the severity of itching[7].
  • In children with allergic cough, Levocetirizine has shown promise in reducing cough frequency and other allergic symptoms[3].

Safety Profile

Levocetirizine is generally well-tolerated. However, like all medications, it can cause side effects. Common side effects may include drowsiness, dry mouth, and fatigue. The safety of the medication has been evaluated in various clinical trials, including long-term studies lasting up to 90 days[3]. It’s important to discuss any concerns about side effects with your healthcare provider.

Comparison with Other Antihistamines

Several studies have compared Levocetirizine to other antihistamines:

  • Levocetirizine vs. Fexofenadine: A study compared these two medications in treating seasonal allergic rhinitis, looking at their effectiveness in reducing symptoms[4].
  • Levocetirizine vs. Loratadine: Comparisons have been made for both perennial allergic rhinitis and chronic idiopathic urticaria, evaluating the efficacy and safety of these two medications[5][7].
  • Levocetirizine vs. Cetirizine: A study compared these closely related antihistamines in reducing symptoms of seasonal allergic rhinitis in subjects exposed to ragweed pollen[6].

These comparison studies help healthcare providers make informed decisions about which antihistamine might be most suitable for individual patients based on their specific symptoms and conditions.

Aspect Details
Drug Name Levocetirizine Dihydrochloride
Common Dosage 5 mg tablet once daily (adults), 0.125 mg/kg twice daily (children 1-2 years)
Conditions Studied Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Chronic Idiopathic Urticaria, Allergic Cough in Children
Primary Outcome Measures Symptom scores (T5SS, MSC), number of comfortable days, pruritus severity
Comparator Drugs Loratadine, Fexofenadine, Cetirizine
Study Designs Randomized, crossover, double-blind, placebo-controlled
Special Populations Adults, children (including 1-2 years old)
Duration of Studies Ranging from 2 weeks to 90 days

FAQ

  • What is Levocetirizine Dihydrochloride used for? Levocetirizine Dihydrochloride is used to treat various allergic conditions, including seasonal and perennial allergic rhinitis (hay fever), chronic idiopathic urticaria (hives), and allergic cough in children.
  • How is Levocetirizine Dihydrochloride administered in clinical trials? In most trials, Levocetirizine Dihydrochloride is administered as a 5 mg tablet once daily. For children aged 1-2 years, it was given as oral drops at a dose of 0.125 mg/kg twice daily.
  • What are the primary outcomes measured in Levocetirizine Dihydrochloride trials? Primary outcomes often include changes in symptom scores, such as the Total 5 Symptom Score (T5SS) for rhinitis, pruritus severity for urticaria, and the number of comfortable days as assessed by the subject.
  • How does Levocetirizine Dihydrochloride compare to other antihistamines? Several trials compare Levocetirizine to other antihistamines like Loratadine, Fexofenadine, and Cetirizine. These studies aim to establish the relative efficacy and safety of Levocetirizine compared to these alternatives.
  • Are there any studies on Levocetirizine Dihydrochloride for children? Yes, there are studies evaluating the efficacy and safety of Levocetirizine in children. One trial specifically looked at its use in treating recurrent cough associated with allergic symptoms in children aged 1-2 years.

Ongoing Clinical Trials on Levocetirizine Dihydrochloride

  • Study on ABCB5+ MSCs for Recessive Dystrophic and Junctional Epidermolysis Bullosa Patients

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Croatia Denmark France Germany Greece +6

  • Study on the Effects of Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis

    Not recruiting

    1 1 1
    Investigated drugs:
    Germany

Glossary

  • Allergic Rhinitis: An allergic reaction that causes inflammation in the nose, often resulting in symptoms like sneezing, runny nose, and nasal congestion.
  • Perennial Allergic Rhinitis: Allergic rhinitis that occurs year-round, often caused by allergens like dust mites or pet dander.
  • Seasonal Allergic Rhinitis: Allergic rhinitis that occurs during specific seasons, typically caused by pollen from trees, grasses, or weeds.
  • Chronic Idiopathic Urticaria: A condition characterized by recurring hives (urticaria) that last for more than six weeks and have no known cause.
  • Bioequivalence: The property of two drugs having the same biological effect and availability in the body.
  • Cmax: The maximum concentration of a drug in the blood after administration.
  • AUC: Area Under the Curve, a measure of the total exposure to a drug over time.
  • T5SS: Total 5 Symptom Score, a measure used to assess the severity of allergy symptoms.
  • Environmental Exposure Unit (EEU): A controlled setting used to expose subjects to specific allergens for research purposes.
  • Pruritus: Severe itching of the skin, a common symptom in allergic reactions and urticaria.

References

  1. https://clinicaltrials.gov/study/NCT01567501
  2. https://clinicaltrials.gov/study/NCT00521131
  3. https://clinicaltrials.gov/study/NCT00520754
  4. https://clinicaltrials.gov/study/NCT00542607
  5. https://clinicaltrials.gov/study/NCT00524836
  6. https://clinicaltrials.gov/study/NCT00544388
  7. https://clinicaltrials.gov/study/NCT00525382